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The effect of spermine on the permeability ransition of the inner mitochondrial membrane of isolated rat heart mitochondria was evaluated. The 
permeability ransition was triggered using a series of agents (t-butyl hydrol~roxide, phenylarsine oxide, carboxyatractylate, nd elevated Ca 2. and 
inorganic phosphate concentrations), and was monitored via Ca'-"-release, mitochondrial swelling and pyridine nueleotide oxidation. By all three 
criteria, spermine inhibited the transition. A Qo of 0.38 + 0.06 (SD) mM was measured for inhibition. 
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1. INTRODUCTION 
The aliphatic polyamines, permine and spermidine, 
were discovered by Antony yon Leeuvenhoek in 1674 
in animal semen [1]. They are, in fact, present at rnilli. 
molar concentrations in the eytosol of most eukaryotic 
cells [1]. Polyamines are required for essential cellular 
functions such as DNA, RNA and protein synthesis, 
and protein phosphorylation [2]. 
Spermine also protects mitochondria from damage. 
For example, spermine prevents loss of respiratory con- 
trol and restores phosphorylation i  heat-aged liver mi- 
tochondria [3]. Toninello [4] has reported that spermine 
blocks the collapse of the membrane potential and the 
release of Mg 2~, adenine nucleotides, and Ca 2~ observed 
when mitochondria re exposed to damaging concen- 
trations of inorganic phosphate (P~) and Ca ~-+. 
Increased matrix Ca ~-÷, in combination with a trigger- 
ing agent, which may be elevated P~ concentration, in- 
creased temperature, oxidative stress or one of a large 
number of chemicals, induces the inner mitochondrial 
membrane (i.m.) to undergo a permeability transition 
allowing entry/efflux of small (<1500 dalton) solutes. 
The permeability transition is Ca2~-dependent and cy- 
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closporin A (CsA)-sensitive. It is accompanied by un- 
coupling, collapse of the membrane potential, oxidation 
of pyridine nucleotides, loss of small matrix solutes in- 
cluding Ca ~-+, swelling and a transition from the aggre- 
gated to the orthodox state (for a review see [5]). 
The permeability transition reflects opening of a pore 
in the i.na. [6,7]. Cyclosporin inhibits pore opening [8], 
possibly by interacting with its intraeellular receptor, 
cyclophilin, a peptidyl-prolyl cis-trans isomeras¢ [9]. 
We propose that the protective ffects of spermine on 
mitochondria reflect inhibition of the i.m. permeability 
transition. In these studies, the permeability transition 
of isolated rat heart mitochondria was monitored via 
Ca "-+ retention, swelling and pyridine nucleotide 
[NAD(P)H] oxidation. A series of agents~ t-butyl- 
hydroperoxide (t-BH), phenylarsine oxide (PhAsO), 
carboxyatractylate (CAT), elevated Ca ~-~ levels and high 
P~ concentration, thought to act by different mecha- 
nisms, was used to trigger the transition. By all criteria, 
spenuine was a good inhibitor of the permeability tran- 
sition in rat heart mitochondria. 
2. MATERIALS AND METHODS 
Heart mitochondria were isolated from male Sprague-Dawley rats 
(350-550 g) using a modification [10] of the procedure described by 
Sordahl [1 II. Experimeat~ were carried oat at 30°C in a amadard resin 
(Chelex-100)-trcated buffer consisting of 100 mM sucrose, 50 mM 
KCI, 20 mM MOPS-KOH (pH 7.2), and 1.7 mM KH,PO~. All data 
reported are representative of multiple (~3) experiments. Protein de- 
terminations were perlbrmed according to Lowry et al. [12] using BSA 
as standard. 
2.1. Mitochandrlal swelling 
Changes in mitoehondria[ volume were measured qualitatively at 
540 nm in an LKB Ultro~pec 11 UV-Vi~ibl¢ zp~etrophotometer [13]. 
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Mitochondria (0.2 mg/ml) were pre-ineubated in standard buffer sup- 
plemented with 0.8/aM rotenone for 3 rain prior to Ca 2" (100 nmol/mg 
protein) addition. Thirty seconds later the mitoehondria were ener- 
gized with 5 raM succinate. When appropriate, a triggering agent was 
added after a farther 2.5 rain. 
2.2. Pyridine mu'leotide [ NAD(  P) H] oxidation 
Reduction and oxidation of NAD(P)H were followed in an SLM- 
Amineo DW-2000 speetrophotometer at the wavelength pair 340-370 
nm [14]. The experimental protocol was identical to that used to 
monitor swelling except hat a higher concentration f mitoehondrial 
protein (0.6 mg/ml) was utilized. A differential extinction coefficient 
of 1.39 M -~ . cm, determined by titration with NADH,  wan used in 
calculations. 
2.3. Ca-' + retention 
Ca-" uptake and release were measured u~ing a Ca:*-selective elec- 
trode [10] and the protocol described above for mitochondrial swel- 
ling. The standard Ca :+ addition was, however, increased to 167 nmol/ 
mg because the time course of Ca :+ release is significantly slower than 
that of swelling. 
2.4. Materials 
Sucrose, HEPES, EGTA, MOPS, BSA, CaCl,, rotenone, protea~e 
type XIV, t-butyl hydroperoxide, carboxyatraetylate, KH.,POa, phen- 
ylarsine oxide, and suecinate were purchased from Sigma Chemical 
Co. (St. Louis, MO). Spermine was from Aldrich (Milwaukee, WI) 
and Chelex-100 from Bio-Rad (Richmond, CA). Cyclo~porin (OL 
27-400) was the gift of Sandoz Research Institute, East Hanover. NJ. 
All other reagents were of the hi/~hest quality available. PhAsO was 
prepared as a 10 mM stock solution in DMSO. 
3. RESULTS 
All of the triggering agents tested induced the release 
of Ca -~÷ from isolated, preloaded rat heart mitochondria 
(Fig. 1A). Ca+-+-release occurred with a lag which was 
decreased by triggering agent; the amount of Ca 2+ re- 
leased was not altered. Spermine (2 mM) substantially 
delayed the Ca+-+-release triggered by each of the agents 
except elevated P~ concentration (Fig. 1B). Note that the 
sensitivity of the Ca~"-electrode is altered when sper- 
mine is present, and electrode response time is markedly 
increased (not shown). 
Spermine (2 raM) also biocked the swelling of iso- 
lated rat heart mitochondria nduced by CAT, PhAsO, 
t.BH, elevated Ca-, and high P~ (Fig. 2). Inhibition of 
swelling induced by CAT, PhAsO, elevated Ca 2., and 
t-BH was significantly greater than inhibition of swel- 
ling triggered by Pi (P < 0.01, Student's t-test). 
The Ca-'+-dependent NAD(P)H oxidation associated 
with the i.m. pernteability transition was likewise inhib- 
ited by spermine (Fig. 3). When heart mitochondria 
were added to buffer containing rotenone, reduction of 
NAD(P)H wa.~ observed (Fig. 3A, trace a). Further re- 
duction resulted upon addition of succinate. Several 
minutes later, a rapid shift of NAD(P)H in the reduced 
direction occurred, indicating the exhaustion of O., [15]. 
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Fig. 1. Effect of spermine on Ca2+-r~tention byisolated rat heart mitochondria. At tile arrows, Ca 2+ (167 nmol/mg mitochondrial protein), succinate 
(5 raM) and tri~.~erin~, agent were added. PhAsO (2.5 aM), Ca:* (400 nmol/mg mitochondrial protein), CAT (10/~M), Pi (10 raM), and t-BH (000 
/aM) were used to trigger Ca 2+ release. When Ca '+ was tim trigl~ering agent, the standard Ca:' addition was inerea~+:d to 400 nmol/mg. Solid and 
broken lines indicate data obtained from 2 different preparations of mitoehoadria. Experiments were ~rried out in the presence (B) or absenc~ 
(A) of 2 mM slxrmine. 
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Fig. 2. Effect of spermine (2 raM) on rate of mitochondrial swelling. 
Conditions were as for Fig. I except he standard Ca :+ addition wad 
reduced to 100 nmol/mg protein and the PhAsO concentration was 50 
,ttM. The rate of swelling was qnantif i~ as ,aA~dmia. Data are the 
mean of 3 experiments. Swelling rates measured in the absence of 
sperminc were 0.032 _ 0.003 (PhAsO), 0.017 _ 0.008 (CAT), 0.010 __. 
0.002 (P3, 0.036 +_ 0.011 (Ca '+) and 0.013 "2_ 0.004 (t-BH). 
This was followed by a slow oxidation of NAD(P)H 
equivalent to 2.4 nmol NAD(P)H/mg p~otein at the time 
the run was completed, This slow NAD(P)H oxidation 
was Ca2*-dependent (not shown) and reflects occur- 
rence of  the transition. It was blocked by spermine 
(trace b) and cyclosporin (trace c), a recognized inhibi- 
tor of the transition [8]. 
When 600/,tM t-BH was used to trigger the i.m. per- 
meability transition (Fig. 3B), NAD(P)H oxidation was 
biphasic (trace a). t-BH addition prompted the oxida- 
tion of a small amount of NAD(P)H. This process was 
unaffected by spermine or CsA. Following O,~ exhaus- 
tion, a second, rapid wave of NAD(P)H oxidation 
equivalent to 2.06 nmol/mg protein was observed. Sper- 
mine slowed (trace b) and cyclosporin eliminated (trace 
0.03 , , ' "" , 
C#* S 
4,4, 
0,02 
c) this second wave. It was also selectively eliminated by 
chelation of Ca 2+ (data not showr,). The occurrence of 
NAD(P)H oxidation linked to the permeability transi- 
tion only after exhaustion of 02 has been reported pre- 
viously [15]. 
The dependence of transition inhibition on sperrrdne 
concentration was determined by measuring swelling 
(Fig. 4). When elevated Ca ~-+ levels were used to trigger 
swelling, the Cs0 for inhibition was 0.38 _ 0.06 (SD) 
mM. Similar results were obtained when Ca~'*-retention 
was monitored (data not shown). 
To further evaluate the mechanism of action of sper- 
mine, the effect of spermin¢ on the Ca2*-dependence of 
the Ca2+-induced permeability transition was deter- 
mined (Fig. 5A). Spermine (2 mM) decreased the rate 
of swelling observed at saturating Ca "~+ concentrations; 
i.e. it was not competitive with Ca 2~. The C50 for Ca 2*- 
induced triggering was increased from 44 ,aM to 65/,tM 
in the presence ofspermine, as was the apparent cooper- 
ativity (Fig. 5B). The slope of the Hill plot increased 
from 3.5 to 4.5. 
A 
4. DISCUSSION 
The experimental results outlined above demonstrate 
that spermine blocks the permeability transition of the 
inner mitochondrial membrane. This is consistent with 
the inhibition of Na~-independent Ca2~ efflux from rat 
brain mitochondria by spermine measured by Rotten- 
berg and Marbach [16]. Inhibition was generally inde- 
pendent of triggering agent, suggesting that spermine 
may act on the pore itself rather than at the level of the 
diverse biochemical processes postulated to modulate 
its opening. 
Spermine was, however, a poor inhibitor of the tran- 
sition triggered by high P~, whether it was monitored via 
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Fig. 3. Effect of spermine on NAD(P)H oxidation. At the arrows, mitochondria (M, 0.6 mg/ml), Ca-'* (100 nmol/mg mitoehondrial protein), and 
sucvinat¢ (S, 5 raM) were added. In Pand B, a triggering agent (600/.tM t-BH) was al~o added. Traces how data obtained inthe absence of'inhibition 
(a), in the pr~,'senee of 2 mM spermine (b), or with 1/,tM CsA (e). 
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Fig, 4. Dependence of inhibition of mitochoadrial swelling on sper- 
mine concentration. Ca:* (400 nmol/mg mitoehondriai protein) was 
used as triggering agent. 100% was equivalent to a swelling rate of 
0.0375/min. Other details as in Fig. 2. 
CaZ*-release (Fig. 1), mitochondrial swelling (Fig. 2), or 
NAD(P)H oxidation (not shown). The binding of posi- 
tively charged spermin¢ (2 raM) to negatively charged 
P~ (10 mM) may effectively decrease spermin¢ concen- 
tration. 
Several mechanisms for spermine action can be pro- 
posed. First, it is possible that spermine decreases mito- 
chondrial Ca:* uptake. The results in Fig. 1 suggest that 
uptake is slowed, bat the effects of spermin¢ on elec- 
trode response make interpretation difficult. Numerous 
authors have reported that spermine plays an important 
role in the regulation of Ca ~* transport in mitochondria 
[17-20], but there is general agreement that spermine 
increases Ca 2~ accumulation. The presence of spermine 
lowers the set point for mitoehondrial buffering of 
extra-mitochondrial free Ca-'" [17,18]. Spermine has 
also been found to lower the apparent K~ of the electro- 
phoretic, Ruthenium red-sensitive Ca -'+ uniporter [17- 
19]. Internal markers have been used to confirm en- 
hanced matrix Ca 2" accumulation i  isolated rat heart, 
kidney and liver mitochondria [18-20]. 
It is possible that spermine nters the mitoehondria 
and competes for the matrix Ca-'~-binding site on or 
near the pore. It has been reported that sperminc is 
transported bidireetionally across the i.m. in both liver 
[21] and heart [22] mitochondria. Uptake is Pi-depend- 
eat but Ca2~'-independent and requires an elevated 
membrane potential (> 180 mV) [4]. The Ka for spermine 
uptake by liver mitochondria (0.5 mM) [21] correlates 
well with the C~0 for spermine inhibition of the permea- 
bility transition (0.38 raM), and is consistent with a 
matrix site of spermine action. The observation that 
spermine inhibition is not overcome by high Ca -~* con- 
centrations (Fig. 5) would argue, however, against a 
competitive action of spermine at the Ca-" site. 
Finally, calcineurin, a Ca-'*- and calmodalinglepend- 
ent protein phosphatase [23], may be involved in the 
mechanism of spermine action. The cyclophilin--cy- 
closporin complex binds to and inhibits calcineurin [24]. 
Spermin¢ inhibits ca!cineurin activity with a C~o of 1.2 
mM [25]. Modulation of pore opening by protein phos- 
phorylation-dephosphorylation reactions would then 
provide a single target for inhibition of the permeability 
transition by both CsA and spermine. 
This work has identified spermine as an inhibitor of 
the mitochondrial permeability transition. The C~a for 
spermine inhibitio~ of the permeability ransition (0.38 
_ 0.06 (SD) mM) thlls into the range (0.3-2 raM) of 
spermine concentrations reported for the cytosol of qui- 
escent cells [26]. Further elucidation of the mechanism 
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Fig. 5. Effect ofspermme on the Ca" -depend=nee of mitochondrial swelling. Experiments were carried out in the ab~cn¢¢ (open symbols) or presence 
" t  (filled symbols~ of 2 mM sperminc. Ca 2~ was used as the trigg=ring agent. Data from four mitochondria preparations (e , . ,  v, , )  are combined. 
Maximal rates of swdling were 0.035/min (control) and 0.0145/rain (2 mM spermine). Panel B is a Hill plot of the data. 
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of spermine action may, therefore, provide physiologi- 
cally important insights into the transition. 
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